Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease

Purpose: To report the 12-month results of the MAJESTIC clinical study of the self-expanding Eluvia paclitaxel-eluting stent in the treatment of femoropopliteal lesions. Methods: The prospective, single-arm, multicenter trial (clinicaltrials.gov identifier NCT01820637) enrolled 57 patients (mean age...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller-Hülsbeck, Stefan, Keirse, Koen, Zeller, Thomas, Schroë, Herman, Diaz-Cartelle, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Lower and Upper Limb Interventions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023034/
https://www.ncbi.nlm.nih.gov/pubmed/27193308
http://dx.doi.org/10.1177/1526602816650206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023034/
https://www.ncbi.nlm.nih.gov/pubmed/27193308
http://dx.doi.org/10.1177/1526602816650206

Ejemplares similares